Evidence map›Paper›PMID 31159839›Full record

ArticleParasites & vectors2019

Cobalt nanoparticles as novel nanotherapeutics against Acanthamoeba castellanii.

Ayaz Anwar, Arshid Numan, Ruqaiyyah Siddiqui, Mohammad Khalid, Naveed Ahmed Khan

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Novel Drug Screening Assay forJournal of medicinal chemistry · 2024
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. CoRSC advances · 2020
    Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ayaz AnwarDepartment of Biological Sciences, School of Science and Technology, Sunway University, 47500, Subang Jaya, Selangor, Malaysia. ayazanwarkk@yahoo.com.
Arshid NumanGraphene and Advanced 2D Materials Research Group, School of Science and Technology, Sunway University, 47500, Subang Jaya, Selangor, Malaysia.
Ruqaiyyah SiddiquiDepartment of Biological Sciences, School of Science and Technology, Sunway University, 47500, Subang Jaya, Selangor, Malaysia.
Mohammad KhalidGraphene and Advanced 2D Materials Research Group, School of Science and Technology, Sunway University, 47500, Subang Jaya, Selangor, Malaysia.
Naveed Ahmed KhanDepartment of Biological Sciences, School of Science and Technology, Sunway University, 47500, Subang Jaya, Selangor, Malaysia.
Sunway University · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSpecies of Acanthamoeba are facultative pathogens which can cause sight threatening Acanthamoeba keratitis and a rare but deadly brain infection, granulomatous amoebic encephalitis. Due to conversion of Acanthamoeba trophozoites to resistant cyst stage, most drugs are found to be ineffective at preventing recurrence of infection. This study was designed to test the antiacanthamoebic effects of different cobalt nanoparticles (CoNPs) against trophozoites and cysts, as well as parasite-mediated host cell cytotoxicity.

methodsThree different varieties of CoNPs were synthesized by utilizing hydrothermal and ultrasonication methods and were thoroughly characterized by X-ray diffraction and field emission scanning electron microscopy. Amoebicidal, encystation, excystation, and host cell cytopathogenicity assays were conducted to study the antiacanthamoebic effects of CoNPs.

resultsThe results of the antimicrobial evaluation revealed that cobalt phosphate Co

conclusionsTo our knowledge, these findings determined, for the first time, the effects of composition, size and morphology of CoNPs against A. castellanii. Co

Indexed as

Acanthamoeba castellaniiAmebiasisAmebicidesCells, CulturedCobaltMicroscopy, Electron, ScanningNanoparticlesTrophozoitesAmebicidesCobaltAcanthamoebaAntimicrobialCobalt nanoparticlesCyst

Identifiers

PMID31159839
PMCPMC6545699
OpenAlexW2948655814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.